Celon Pharma S.A. (WSE:CLN)

Celon Pharma Revenue

Celon Pharma had revenue of 61.29M PLN in the quarter ending March 31, 2026, with 24.87% growth. This brings the company's revenue in the last twelve months to 256.54M, up 18.95% year-over-year. In the year 2025, Celon Pharma had annual revenue of 244.34M with 18.87% growth.

• Revenue (ttm): 256.54M
• Revenue Growth: +18.95%
• P/S Ratio: 4.15
• Revenue / Employee: 454.86K
• Employees: 564
• Market Cap: 1.07B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	244.34M	38.79M	18.87%
Dec 31, 2024	205.55M	-9.12M	-4.25%
Dec 31, 2023	214.66M	20.78M	10.72%
Dec 31, 2022	193.89M	-2.20M	-1.12%
Dec 31, 2021	196.09M	38.64M	24.54%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 4, 2026

Data Sources Report a data error